Poxviruses as vaccine vectors

The discovery of Jenner in 1798 founded the science of immunology and eventually led to smallpox eradication from the earth in 1980 after a world-wide vaccination campaign with vaccinia virus (another poxvirus) and paradoxically, despite the eradication of smallpox, there has been an explosion of interest in vaccinia virus in the eighties. This interest has stemmed in part from the application of molecular genetics to clone and express foreign genes from recombinant vaccinia viruses. Vaccinia is also gaining renewed interest due to bioterrorism.

These recombinant viruses have multiple applications in research and vaccinology and led to the development of vectored vaccines, such as the recombinant vaccinia rabies vaccine used to eliminate rabies in Western Europe and, more recently, in the United States. Secondly, alternative poxvirus vectors, such as avipox viruses, were proved to be even safer and efficacious non-replicating vectors (suiciole vectors) when used in non-avian species.     

福建省羊传染性脓疱病毒F1L、B2L和VIR基因的遗传变异分析

为探明2014年-2015年在福建省流行的羊传染性脓疱病毒(ORFV)遗传变异情况,对10株ORFV流行毒株的F1L、B2L和VIR基因进行克隆、测序及分析。结果表明,10株ORFV F1L基因之间的核苷酸序列同源性为97.6%~100%,与国内株的核苷酸序列同源性为96.8%~99.7%,与NZ2参考株的核苷酸序列同源性为96.3%~97.1%;同NZ2参考株比较,FJ-YT2014缺失2个氨基酸;10株ORFV B2L基因之间核苷酸序列同源性为97.5%~99.9%,与国内株的核苷酸序列同源性为96.7%~99.5%,与NZ2参考株的核苷酸序列同源性为96.7%~97.7%;10株ORFV VIR基因之间的核苷酸序列同源性为95.8%~99.5%,与国内株的核苷酸序列同源性为94.6%~99.6%,与NZ2参考株的核苷酸序列同源性为94.6%~96.4%。基于基因核苷酸序列的遗传进化分析表明,10株ORFV F1L基因与福建省分离株、山西株和新疆株亲缘关系较近;10株ORFV B2L基因与新疆、山西、德国毒株亲缘关系较近;10株ORFV VIR基因与台湾、新疆株亲缘关系较近。结果提示,当前福建省流行的ORFV F1L、B2L和VIR基因尚未出现明显变异,但是其F1L、B2L和VIR基因核苷酸序列之间普遍存在异质性。     

禽流感病毒H9N2亚型三重PCR检测方法的建立

为建立简便快速检测禽流感病毒(avian influenza virus,AIV)并同时区分出H9、N2亚型的方法,本试验根据基因库中H9亚型AIV的HA基因、N2亚型AIV的NA基因及AIV的M基因序列,分别设计了3对针对这3种基因保守序列的引物,建立了AIV H9N2亚型的三重PCR检测方法。应用该方法对H9N2亚型AIV模板进行PCR扩增,可得到3条与试验设计相符的目的条带,分别为313 bp (HA基因)、451 bp (NA基因)和667 bp(M基因);对非H9亚型的N2亚型AIV模板进行扩增,出现2条特异性扩增条带,即451 bp (NA基因)和667 bp(M基因);对非H9、N2亚型AIV模板进行扩增则只出现一条目的条带,即667 bp(M基因);对其他禽呼吸道病原体进行PCR扩增,结果均为阴性。敏感性试验结果显示此三重PCR方法最低检出限为10^-2 ng/μL。应用所建立的三重PCR方法对120份临床病料进行检测的结果与病毒分离鉴定结果一致。各项试验结果均表明,该方法对于禽流感病毒尤其是H9、N2亚型禽流感病毒的检测具有快捷、特异、灵敏的特点。     

模猪场猪瘟野毒感染情况调查

利用ELISA方法对广西6个规模猪场送检的1626份猪血清进行猪瘟野毒感染情况调查。结果6个规模猪场均存在猪瘟野毒感染,其中母猪感染率为7.86%~29.21%,平均为17.52%,种公猪感染率为0%~23.52%,平均为11.83%,育肥猪感染率为5%~22.45%,平均为15.5%,断奶仔猪感染率为8.24%~18.57%,平均为12.69%。此检测结果与猪场临床发病情况基本一致,病猪多表现为繁殖障碍型、温和型的非典型猪瘟。     

S2基因失活突变马传染性贫血病毒感染性克隆的构建及感染性研究

为研制马传染性贫血病毒(EIAV)标记疫苗株,本研究在EIAV驴胎皮肤(FDD)细胞弱毒疫苗株感染性克隆pEIAVFDDV3-8的S2基因内部引入两个终止密码子,致使S2基因终止表达,构建了一株S2基因突变的感染性克隆pEIAVFDDV3-8△S2。用该重组质粒转染FDD细胞,盲传至第4代时,转染细胞病变明显,电镜下可见细胞内的典型病毒颗粒。反转录酶活性检测和Real-time PCR对病毒拷贝数的检测均证明,获得了EIAVS2基因终止表达的感染性克隆毒株,命名为EIAVFDDV3-8△S2。     

逆向遗传学技术在猪瘟病毒研究中的应用

猪瘟是猪的最严重疾病之一,其病原 是猪瘟病毒,基因组为单股正链RNA。猪瘟 弱毒疫苗在猪瘟的免疫防治中发挥了巨大作 用,但由于弱毒疫苗免疫的动物不能从血清 学上与自然感染动物区分,使其应用受到很 大限制,研制标记疫苗是解决这个问题的重 要途径。由于RAN的结构不稳定成为阻碍 RNA病毒研究的主要障碍,所以病毒分子生 物学是新型猪瘟疫苗研究的必要手段。近年 来兴起的逆向遗传研究将RNA病毒的基因 组转化为cDNA,文章就猪瘟病毒逆向遗传 研究的意义、方法、概况及其在猪瘟新型疫苗 研究中的应用进行了全面综述。     

1株高致病性血凝性脑脊髓炎病毒的分离与鉴定

利用细胞培养方法从临床表现神经症状的死亡仔猪脑组织内分离获得1株病毒,同时对该病毒进行电镜负染观察、昆明种小鼠致病性试验、RT-PCR检测和部分基因测序分析。电镜观察可见细胞培养物中有大量的直径约115 nm的冠状病毒样粒子;接种病毒的小鼠均出现典型的神经症状,死亡率100%;血凝性脑脊髓炎病毒(HEV)特异性引物RT-PCR扩增结果阳性;其S基因序列与GenBank中登录的HEV-67 N相应基因序列的同源性高达99.6%。结果表明,分离的病毒为猪血凝性脑脊髓炎病毒,分离株暂命名为HEV-CC-2007。     

Preliminary clinical pharmacological investigations of tylosin and tiamulin in chickens

Summary

The minimal inhibitory concentrations (M1C) of tiamulin and tylosin for mycoplasma. Gram‐positive, and Gram‐negative micro‐organisms isolated from chickens were determinated by the agar dilution method. Median M1C values for tiamulin against Mycoplasma gallisepticum (0.05 μg/ml) and Mycoplasma synoviae (0.10 μg/ml) were 2 to 4 times lower than the corresponding values for tylosin. Tiamulin was also slightly more effective in vitro in inhibiting Escherichia coli, Pasteurella multocida, and beta‐haemolytic streptococci than was tylosin. Groups of chicken were offered tiamulin medicated drinking water at rates of 125 and 250 mg/litre for 48 hours. Average serum tiamulin concentrations were 0.38 and 0.78 μg/ml, respectively. When tylosin tartrate was added to the drinking water at 500 and 700 mg/litre, average serum drug levels were 0.12 and 0.17 μg/ml, respectively.

Tiamulin was 45% bound in chicken serum, as against 30% serum protein binding or tylosin. Correlations were made between free (non protein bound) serum drug levels and the MIC values of the two drugs. Such comparisons suggest that when tiamulin is given in the drinking water at rates of 125 to 250 mg/litre, better antimycoplasmal activity is to be expected in vivo than by giving tylosin tartrate in the drinking water at 500 to 700 mg/litre. Based on these data, no clinical efficacy of these dose rates can be expected in flocks infected by gram‐negative microorganisms such as E. coli or P. multocida. The tylosin tartrate rate of 500 to 700 mg/litre, may be clinical ineffective the treatment of Staphylococcus aureus infections.     

Association between bovine-leukosis virus seroprevalence and herd-level productivity on US dairy farms

Bovine-leukosis virus (BLV; also termed ‘bovine-leukemia virus’) is a retrovirus that primarily affects lymphoid tissue of dairy and beef cattle. Our objective was to investigate the association between BLV infection and annual value of production (AVP) on dairy herds within the United States, as part of the USDA National Animal Health Monitoring System’s 1996 dairy study. 1006 herds (in 20 states) with at least 30 dairy cows were interviewed during 1996. The agar-gel immunodiffusion test was used to detect serum antibodies to BLV. 10–40 cows from each herd were tested and each tested cow was classified as negative or positive based on results of a single test.

A multivariable regression model was used with the 976 herds with complete data for analysis. When compared to herds with no test-positive cows, herds with test-positive cows produced 218 kg per cow (i.e. 3%) less milk. The average reduction in AVP was $ 59 per cow for test-positive herds relative to test-negative herds. For the dairy industry as a whole, BLV seropositivity was associated with loss to producers of $ 285 million and $ 240 million for consumers. Most of this $ 525 million industry loss was due to reduced milk production in test-positive herds.     

番鸭小鹅瘟病胶乳凝集试验与病毒分离的比较研究

应用GPV胶乳凝集方法（LPA）和病毒分离（VI）检测人工感染病例9份、健康对照6份,临床疑似送检病鸭28份。其中人工感染样品检测LPA和VI符合率为93.3%（14/15）;临床疑似样品检测LPA和VI符合率为89.3%（25/28）;两者总符合率达90.7%（39/43）。LPA方法具有简便（肉眼可判定,不需仪器）、快速（检测抗原20min内）、特异、准确等优点,比VI更适合临床使用。